Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05723562 |
| Title | A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1) |
| Acronym | AZUR-1 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | DEU | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Los Angeles | California | 90027 | United States | Details | |
| GSK Investigational Site | Albuquerque | New Mexico | 87131 | United States | Details | |
| GSK Investigational Site | New York | New York | 10022 | United States | Details | |
| GSK Investigational Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
| GSK Investigational Site | Dallas | Texas | 75390 | United States | Details | |
| GSK Investigational Site | Richmond | Virginia | 23298 | United States | Details | |
| GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Montreal | Quebec | H2X 0C1 | Canada | Details | |
| GSK Investigational Site | Sherbrooke | Quebec | J1H 5N4 | Canada | Details | |
| GSK Investigational Site | Besançon | 25030 | France | Details | ||
| GSK Investigational Site | Marseille | 13273 | France | Details | ||
| GSK Investigational Site | Paris | 75012 | France | Details | ||
| GSK Investigational Site | Pessac | 33604 | France | Details | ||
| GSK Investigational Site | Rennes | 35000 | France | Details | ||
| GSK Investigational Site | Berlin | 13353 | Germany | Details | ||
| GSK Investigational Site | Dresden | 01307 | Germany | Details | ||
| GSK Investigational Site | Düsseldorf | 40225 | Germany | Details | ||
| GSK Investigational Site | Frankfurt | 60488 | Germany | Details | ||
| GSK Investigational Site | München | 81377 | Germany | Details | ||
| GSK Investigational Site | Milan | 20133 | Italy | Details | ||
| GSK Investigational Site | Padua | 35128 | Italy | Details | ||
| GSK Investigational Site | Roma | 00168 | Italy | Details | ||
| GSK Investigational Site | Chiba | 277-8577 | Japan | Details | ||
| GSK Investigational Site | Kanagawa | 232-0024 | Japan | Details | ||
| GSK Investigational Site | Osaka | 540-0006 | Japan | Details | ||
| GSK Investigational Site | Osaka | 565-0871 | Japan | Details | ||
| GSK Investigational Site | Utrecht | 3584 CX | Netherlands | Details | ||
| GSK Investigational Site | Seoul | 05505 | South Korea | Details | ||
| GSK Investigational Site | Seoul | 06591 | South Korea | Details | ||
| GSK Investigational Site | Seoul | 120-752 | South Korea | Details | ||
| GSK Investigational Site | Seoul | 135-710 | South Korea | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Granada | 18014 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28007 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28041 | Spain | Details | ||
| GSK Investigational Site | Santander | 39008 | Spain | Details | ||
| GSK Investigational Site | Valencia | 46010 | Spain | Details | ||
| GSK Investigational Site | Leeds West Yorkshire | LS9 7TF | United Kingdom | Details | ||
| GSK Investigational Site | London | EC1A 7BE | United Kingdom | Details | ||
| GSK Investigational Site | Sutton | SM2 5PT | United Kingdom | Details |